<DOC>
	<DOCNO>NCT01364259</DOCNO>
	<brief_summary>Trigeminal neuralgia tic douloureux severe , often debilitate , facial pain significantly impair patient 's quality life health . Stereotactic radiosurgery show provide pain relief majority patient treat . However , common side effect radiosurgery facial numbness . Our goal maximize pain control minimize side effect . To end , purpose study evaluate whether add drug , amifostine , time radiosurgery protect patient facial numbness .</brief_summary>
	<brief_title>A Study Amifostine Prevention Facial Numbness Radiosurgery Treatment Trigeminal Neuralgia</brief_title>
	<detailed_description>Patients evaluate multi-disciplinary team compose radiation oncologist neurosurgeon . Pretreatment pain , neurologic function ( include facial numbness ) , health relate quality life assess . Patients treat single session 75 Gy maximal dose cover 6 mm segment retrogasserian cisternal portion trigeminal sensory root . Treatment deliver use CyberKnife Robotic Radiosurgery System patient supine position . An aquaplast head mask use ensure adequate immobilization therapy . The target volume shall 6 mm segment retrogasserian cisternal portion trigeminal sensory root . Patients receive subcutaneous injection amifostine ( 500 mg ) placebo 30 minute +/- 30 minute prior SRS . Facial pain assess use Visual Analog Scale Short-form McGill Pain Questionnaire . Following SRS , patient follow 1 , 3 , 6 , 9 month Â±7 day . Facial numbness assess use Barrow Neurologic Institute ( BNI ) Facial Numbness Score . Patient report BNI facial numbness score complete cranial nerve exam physician perform pre-treatment follow-up visit .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Trigeminal Neuralgia</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>All patient age 18 year old typical trigeminal neuralgia , determine diagnostic criterion set International Headache Society , : Intolerant refractory medical management ; AND Not candidate refuse surgical microvascular decompression . Patients present preexist BNI grade III IV facial numbness . Patients previously treat MVD . Patients previously ablative treatment , include prior SRS . Pediatric patient ( age &lt; 18 ) , pregnant woman , patient unable give inform consent exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>tic douloureux</keyword>
</DOC>